首页> 外文期刊>Disease models & mechanisms: DMM >A tissue-engineered humanized xenograft model of human breast cancer metastasis to bone
【24h】

A tissue-engineered humanized xenograft model of human breast cancer metastasis to bone

机译:组织工程化的人乳腺癌向骨转移的人源化异种移植模型

获取原文
           

摘要

The skeleton is a preferred homing site for breast cancer metastasis. To date, treatment options for patients with bone metastases are mostly palliative and the disease is still incurable. Indeed, key mechanisms involved in breast cancer osteotropism are still only partially understood due to the lack of suitable animal models to mimic metastasis of human tumor cells to a human bone microenvironment. In the presented study, we investigate the use of a human tissue-engineered bone construct to develop a humanized xenograft model of breast cancer-induced bone metastasis in a murine host. Primary human osteoblastic cell-seeded melt electrospun scaffolds in combination with recombinant human bone morphogenetic protein 7 were implanted subcutaneously in non-obese diabetic/severe combined immunodeficient mice. The tissue-engineered constructs led to the formation of a morphologically intact ‘organ’ bone incorporating a high amount of mineralized tissue, live osteocytes and bone marrow spaces. The newly formed bone was largely humanized, as indicated by the incorporation of human bone cells and human-derived matrix proteins. After intracardiac injection, the dissemination of luciferase-expressing human breast cancer cell lines to the humanized bone ossicles was detected by bioluminescent imaging. Histological analysis revealed the presence of metastases with clear osteolysis in the newly formed bone. Thus, human tissue-engineered bone constructs can be applied efficiently as a target tissue for human breast cancer cells injected into the blood circulation and replicate the osteolytic phenotype associated with breast cancer-induced bone lesions. In conclusion, we have developed an appropriate model for investigation of species-specific mechanisms of human breast cancer-related bone metastasis in vivo .
机译:骨骼是乳腺癌转移的首选归巢位点。迄今为止,骨转移患者的治疗选择大多是姑息性的,该病仍无法治愈。确实,由于缺乏合适的动物模型来模拟人肿瘤细胞向人骨微环境的转移,因此与乳腺癌的骨质疏松有关的关键机制仍仅被部分理解。在提出的研究中,我们调查了人类组织工程化的骨构建体在小鼠宿主中发展乳腺癌诱导的骨转移的人源化异种移植模型的用途。将原代人成骨细胞播种的融体电纺丝支架与重组人骨形态发生蛋白7组合皮下植入非肥胖/糖尿病/严重合并免疫缺陷小鼠。组织工程化的构建体导致形成了形态完整的“器官”骨,其中整合了大量矿化组织,活骨细胞和骨髓腔。如人类骨细胞和人类来源的基质蛋白的结合所表明的,新形成的骨骼在很大程度上被人源化了。心内注射后,通过生物发光成像检测表达荧光素酶的人乳腺癌细胞系向人源化骨小骨的分布。组织学分析显示,在新形成的骨骼中存在明显的骨溶解的转移灶。因此,人类组织工程化的骨构建体可以有效地用作注射到血液循环中的人类乳腺癌细胞的靶组织,并复制与乳腺癌引起的骨病变相关的溶骨表型。总之,我们已经开发出一种合适的模型,用于研究体内人类乳腺癌相关骨转移的物种特异性机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号